XML 46 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-based Compensation
9 Months Ended
Dec. 31, 2013
Stock-based Compensation  
Stock-based Compensation

Note 5 - Stock-based Compensation

 

Amounts recognized in the condensed consolidated financial statements related to stock-based compensation are as follows (in thousands, except per share data):

 

 

 

Three Months Ended
December 31,

 

Nine Months Ended
December 31,

 

 

 

2013

 

2012

 

2013

 

2012

 

Total cost of stock-based compensation charged against income before income taxes

 

$

272

 

$

459

 

$

629

 

$

897

 

Amount of income tax benefit recognized in earnings

 

98

 

163

 

228

 

314

 

Amount charged against net income

 

$

174

 

$

296

 

401

 

583

 

Impact on net income per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.05

 

$

0.09

 

$

0.12

 

$

0.17

 

Diluted

 

0.05

 

0.08

 

0.11

 

0.17

 

 

Stock-based compensation expense is included in cost of revenues, selling, and general and administrative expense in the accompanying condensed consolidated statements of income.

 

The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model (“Black-Scholes”). We use historical data to estimate the expected price volatility, the expected stock option life and expected forfeiture rate. The risk-free interest rate is based on the United States Treasury yield curve in effect at the time of grant for the estimated life of the stock option. The dividend yield is calculated based upon the dividend payments made during the prior four quarters as a percent of the average stock price for that period.

 

The following is a summary of stock option activity for the nine months ended December 31, 2013:

 

 

 

Number of
Shares

 

Weighted-
Average Exercise
Price per Share

 

Weighted-
Average
Remaining
Contractual
Term

 

Aggregate
Intrinsic Value
(000s)

 

Outstanding at March 31, 2013

 

416,125

 

$

29.87

 

3.7

 

$

9,529

 

Stock options granted

 

128,124

 

55.33

 

6.3

 

 

 

Stock options forfeited

 

(17,680

)

44.21

 

 

 

 

 

Stock options expired

 

 

 

 

 

 

 

Stock options exercised

 

(66,140

)

21.85

 

 

 

 

 

Outstanding at December 31, 2013

 

460,429

 

37.57

 

4.4

 

18,884

 

 

 

 

 

 

 

 

 

 

 

Exercisable at December 31, 2013

 

192,570

 

25.59

 

3.1

 

10,204

 

 

The total intrinsic value of stock options exercised was $2,889,000 and $1,800,000 for the nine months ended December 31, 2013 and 2012, respectively.

 

A summary of the status of our unvested stock option shares as of December 31, 2013 is as follows:

 

 

 

Number of
Shares

 

Weighted-
Average
Grant-Date
Fair Value

 

Unvested at March 31, 2013

 

257,805

 

$

9.55

 

Stock options granted

 

128,124

 

15.90

 

Stock options forfeited

 

(17,270

)

10.32

 

Stock options vested

 

(100,800

)

8.54

 

Unvested at December 31, 2013

 

267,859

 

13.01

 

 

As of December 31, 2013, there was $ 2,407,000 of total unrecognized compensation expense related to unvested stock options.  As of December 31, 2013, we have 200,376 shares available for future stock option grants.

 

Effective November 30, 2012, as part of our Chief Financial Officer transition, 14,400 unvested options were modified to a) extend the expiration date to 10 years following the original grant date, b) allow them to be exercised through their expiration date, and c) accelerate the vesting such that all options would vest by November 30, 2014.  This was a modification of the terms of an equity award and, accordingly, we treated this as an exchange of the original award for a new award.  We recorded incremental compensation expense of approximately $240,000 for the three and nine months ended December 31, 2012, which is included in general and administrative expense on the accompanying condensed consolidated statements of income.